Mc Guire Investment Group, LLC Sangamo Therapeutics, Inc Transaction History

Mc Guire Investment Group, LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Jan 13, 2022	SELL	$7.29 - $10.97 $1.67 Million - $2.51 Million	-228,810 Closed	0 $0
Q3 2021 Oct 19, 2021	SELL	$9.01 - $12.01 $152,341 - $203,065	-16,908 Reduced 6.88%	228,810 $2.06 Million
Q2 2021 Jul 16, 2021	SELL	$10.17 - $12.64 $275,434 - $342,329	-27,083 Reduced 9.93%	245,718 $2.94 Million
Q1 2021 Apr 20, 2021	BUY	$10.88 - $17.05 $2.63 Million - $4.13 Million	242,146 Added 789.91%	272,801 $3.42 Million
Q4 2020 Jan 13, 2021	BUY	$9.23 - $18.18 $82,562 - $162,620	8,945 Added 41.2%	30,655 $478,000
Q3 2020 Oct 19, 2020	SELL	$9.38 - $12.48 $10,224 - $13,603	-1,090 Reduced 4.78%	21,710 $205,000
Q2 2020 Jul 14, 2020	BUY	$6.21 - $11.83 $6,210 - $11,830	1,000 Added 4.59%	22,800 $204,000
Q1 2020 Apr 02, 2020	BUY	$5.05 - $8.85 $5,050 - $8,850	1,000 Added 4.81%	21,800 $139,000
Q4 2019 Jan 07, 2020	BUY	$8.03 - $11.7 $69,861 - $101,790	8,700 Added 71.9%	20,800 $174,000
Q3 2019 Oct 25, 2019	BUY	$9.05 - $12.22 $109,505 - $147,862	12,100 New	12,100 $110,000

115

56.4M

576K

1.17M

Ticker SGMO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 156,552,992
Market Cap $391M
Description
Sangamo Therapeutics, Inc., a clinical-stage biotechnology company, focuses on translating science into genomic medicines that transform patients' lives using platform technologies in gene therapy, cell therapy, genome editing, and genome regulation. The company offers zinc finger protein (ZFP), a technology platform for making zinc finger nucle...

Get notified when there are updates to the investment portfolio of Mc Guire Investment Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Mc Guire Investment Group, LLC with notifications on news.